FARABEGOLI, FULVIA

FARABEGOLI, FULVIA  

DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE  

Ricercatori  

FARABEGOLI F.; F .FARABEGOLI; FARABEGOLI FU  

Mostra records
Risultati 1 - 20 di 26 (tempo di esecuzione: 0.029 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
(-)-Epigallocatechin-3-gallate down regulates estrogen receptor alpha function in MCF-7 breast carcinoma cells F. Farabegoli; C. Barbi; E. Lambertini; R. Piva 2007-01-01 CANCER DETECTION AND PREVENTION - 1.01 Articolo in rivista -
(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Farabegoli F.; Papi A.; Orlandi M. 2011-01-01 BIOSCIENCE REPORTS - 1.01 Articolo in rivista -
(-)-epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line Farabegoli F.; Papi A.; Bartolini G.; Ostan R.; Orlandi M. 2010-01-01 PHYTOMEDICINE - 1.01 Articolo in rivista -
A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines. Farabegoli F; Govoni M; Ciavarella C; Orlandi M; Papi A. 2014-01-01 BIOMED RESEARCH INTERNATIONAL - 1.01 Articolo in rivista BMRI2014.pdf853086.pdf
Betalains increase vitexin-2-O-xyloside cytotoxicity in CaCo-2 cancer cells Farabegoli, F.; Scarpa, E.S.; Frati, A.; Serafini, G.; Papi, A.; Spisni, E.; Antonini, E.; Benede...tti, S.; Ninfali, P 2017-01-01 FOOD CHEMISTRY - 1.01 Articolo in rivista Farabegoli2017Copertina_GENERICA_UNIBO_postprint_IRIS-1.pdf
EGCG mediated targeting of deregulated signaling pathways and non-coding rnas in different cancers: Focus on JAK/STAT, Wnt/β-catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL mediated signaling pathways Farooqi A.A.; Pinheiro M.; Granja A.; Farabegoli F.; Reis S.; Attar R.; Sabitaliyevich U.Y.; Xu B....; Ahmad A. 2020-01-01 CANCERS - 1.01 Articolo in rivista cancers-12-00951.pdf
EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion Farabegoli, Fulvia; Govoni, Marzia; Spisni, Enzo; Papi, Alessio 2017-01-01 BIOSCIENCE REPORTS - 1.01 Articolo in rivista BSR20170168.full.pdf
Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement Carmen Ciavarella, Ilenia Motta, Santino Blando, Sabrina Valente, Fulvia Farabegoli, Maria Letizi...a Focarete, Mauro Gargiulo, Gianandrea Pasquinelli 2022-01-01 BIOMEDICINES - 1.01 Articolo in rivista biomedicines-10-01276-v2.pdf
Epigallocatechin-3-gallate and 6-OH-11-O-hydroxyphenanthrene limit BE(2)-C neuroblastoma cell growth and neurosphere formation in vitro Farabegoli, Fulvia*; Govoni, Marzia; Spisni, Enzo; Papi, Alessio 2018-01-01 NUTRIENTS - 1.01 Articolo in rivista nutrients-10-01141.pdf
Epigallocatechin-3-gallate Delivered in Nanoparticles Increases Cytotoxicity in Three Breast Carcinoma Cell Lines Farabegoli F.; Granja A.; Magalhaes J.; Purgato S.; Voltattorni M.; Pinheiro M. 2022-01-01 ACS OMEGA - 1.01 Articolo in rivista -
Epigallocatechin-3-Gallate Delivery in Lipid-Based Nanoparticles: Potentiality and Perspectives for Future Applications in Cancer Chemoprevention and Therapy Farabegoli, Fulvia; Pinheiro, Marina 2022-01-01 FRONTIERS IN PHARMACOLOGY - 1.01 Articolo in rivista -
Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines Papi, Alessio; Govoni, Marzia; Ciavarella, Carmen; Spisni, Enzo; Orlandi, Marina; Farabegoli, Fulvia 2016-01-01 CURRENT CANCER DRUG TARGETS - 1.01 Articolo in rivista -
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. Farabegoli F.; Vettraino M.; Manerba M.; Fiume L.; Roberti M.; Di Stefano G. 2012-01-01 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES - 1.01 Articolo in rivista -
Green tea in human cancer F. Farabegoli 2005-01-01 MINERVA BIOTECNOLOGICA - 1.01 Articolo in rivista -
Lactate is a potential promoter of tamoxifen resistance in MCF7 cells Rossi V.; Govoni M.; Farabegoli F.; Di Stefano G. 2022-01-01 BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS - 1.01 Articolo in rivista -
Molecules Present in Plant Essential Oils for Prevention and Treatment of Colorectal Cancer (CRC) Petrocelli, Giovannamaria; Farabegoli, Fulvia; Valerii, Maria Chiara; Giovannini, Catia; Sardo, A...lberto; Spisni, Enzo 2021-01-01 MOLECULES - 1.01 Articolo in rivista molecules-26-00885.pdf
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells Marinella Roberti, Fabrizio Schipani, Greta Bagnolini, Domenico Milano, Elisa Giacomini, Federico... Falchi, Andrea Balboni, Marcella Manerba, Fulvia Farabegoli, Francesca De Franco, Janet Robertson, Saverio Minucci, Isabella Pallavicini, Giuseppina Di Stefano, Stefania Girotto, Roberto Pellicciari, and Andrea Cavalli 2019-01-01 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - 1.01 Articolo in rivista -
Simultaneous chromosome 1q gain and 16q loss is associated with steroid receptor presence and low proliferation in breast carcinoma. F. Farabegoli; M.A.J.A. Hermsen; C. Ceccarelli; D. Santini; M.M. Weiss; G.A. Meijer and P.J. van ...Diest 2004-01-01 MODERN PATHOLOGY - 1.01 Articolo in rivista -
SOCS-2 expression in MCF-7 and MDA-MB-231 cells F .Farabegoli; M. Govoni 2008-01-01 CELLULAR ONCOLOGY - 4.02 Riassunto (Abstract) -
Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma F. Farabegoli; C. Ceccarelli; D. Santini; M.Taffurelli 2005-01-01 JOURNAL OF CLINICAL PATHOLOGY - 1.01 Articolo in rivista -